Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$949K Hold
5,090
0.36% 66
2017
Q2
$877K Hold
5,090
0.36% 67
2017
Q1
$835K Sell
5,090
-100
-2% -$16.6K 0.37% 64
2016
Q4
$759K Sell
5,190
-200
-4% -$30.1K 0.38% 65
2016
Q3
$899K Sell
5,390
-60
-1% -$10.1K 0.4% 66
2016
Q2
$829K Sell
5,450
-107
-2% -$16.6K 0.39% 65
2016
Q1
$833K Hold
5,557
0.4% 64
2015
Q4
$902K Hold
5,557
0.4% 69
2015
Q3
$769K Hold
5,557
0.36% 67
2015
Q2
$853K Hold
5,557
0.34% 75
2015
Q1
$888K Hold
5,557
0.34% 80
2014
Q4
$885K Sell
5,557
-10
-0.2% -$1.56K 0.34% 83
2014
Q3
$782K Sell
5,567
-800
-13% -$104K 0.31% 93
2014
Q2
$754K Sell
6,367
-200
-3% -$23.2K 0.29% 96
2014
Q1
$810K Buy
6,567
+10
+0.2% +$1.21K 0.33% 95
2013
Q4
$748K Buy
6,557
+6
+0.1% +$683 0.34% 101
2013
Q3
$733K Sell
6,551
-200
-3% -$21.7K 0.37% 92
2013
Q2
$666K Buy
+6,751
New +$701K 0.43% 74

Other funds holding AMGN

FIC Capital's AMGN Position: Q3 2017 in Review

FIC Capital held its Amgen (AMGN) position steady in Q3 2017 at 5,090 shares worth $949K. The position accounts for 0.36% of the portfolio, ranked #66.

FIC Capital first reported a position in AMGN in Q2 2013 and has held it in 18 quarters since. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • FIC Capital held 5,090 shares of Amgen worth $949K as of Q3 2017.
  • FIC Capital left its Amgen share count unchanged in Q3 2017.
  • Amgen made up 0.36% of FIC Capital's portfolio in Q3 2017, its #66 holding.
  • FIC Capital first reported a position in Amgen in Q2 2013 and has held it in 18 quarters since.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.